成都脉管畸形怎样办老烂腿在成都那家医院好一点,成都治海绵状血管瘤的好医院,成都鲜红斑痣科医院,成都下肢动脉硬化中医治疗方法,成都精索静脉曲张科病医院,成都治血糖足的好医院,成都治疗静脉血栓的中医

SAN FRANCISCO, June 22 (Xinhua) -- Apple Inc. has been awarded a long sought-after patent for touch screen functionality on portable devices, a set of exclusive rights expected to play into its current litigation against its counterparts in the mobile device market, U.S. media reported on Wednesday."A computer-implemented method, for use in conjunction with a portable multifunction device with a touch screen display, comprises displaying a portion of page content, including a frame displaying a portion of frame content and also including other content of the page, on the touch screen display," the U.S. Patent and Trademark Office patent abstract reads.Apple filed for the patent in December, 2007.Apple's patent essentially gives it ownership of the capacitive multitouch interface the company pioneered with its iPhone, on- line computer magazine PCMag quoted a source who has been involved in intellectual property litigation on similar matters as saying.The latest patent could produce a new round of lawsuits over the now-ubiquitous multitouch interfaces used in smartphones made by the likes of HTC, Samsung, Motorola, Research in Motion, Nokia, and others that run operating systems similar in nature to Apple's iOS, like Google's Android, said the patent expert.Apple has not immediately responded to request for comment on whether it will use the latest patent against competitors.Apple is currently involved in several patent-related battles with other companies. Nokia sued Apple in October 2009 for allegedly infringing patents the Finnish phone maker owns related to wireless handsets.Apple countersued Nokia in December 2009, accusing Nokia of infringing 13 Apple patents related to the iPhone. Nokia lodged a complaint later with the U.S. International Trade Commission, charging Apple of infringing seven Nokia patents "in virtually all of its mobile phones, portable music players and computers."Last Monday, Nokia said Apple had agreed to pay the Finnish company a license fee to settle all patent litigation between the two. Industry watchers said Nokia is likely to get around 608 million U.S. dollars from Apple.This April, Apple filed a lawsuit against Samsung, alleging that the Korean consumer electronics company has violated Apple's intellectual property in the design of its mobile devices, such as iPhone and iPad.Samsung later sued Apple separately in Asia, Europe and the United States, accusing Apple of infringing Samsung's 10 patents related to mobile phones.

BEIJING, July 11 (Xinhuanet) -- U.S. federal government officially announced that it denied the medical use of marijuana."Department of Health and Human Services concluded that marijuana has a high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision," U.S. Department of Justice declared Friday.The announcement will keep marijuana in the classification of dangerous, addictive drug as heroin.The decision comes almost nine years after medical marijuana advocates asked the government to reclassify marijuana, as its therapeutic effectiveness in treating some diseases and relieving pain of patients.Joe Elford, the chief counsel for Americans for Safe Access (ASA), said he was not surprised by the government's disapproval."It is clearly motivated by a political decision that is anti-marijuana," He noted.This is the third petition to reclassify marijuana has failed to be approved. The former two were filed in 1972 and in 1995, respectively.

HOUSTON, July 25 (Xinhua) -- A shelter-in-place was ordered after a battery caught fire during a testing at NASA's Johnson Space Center Monday morning.A battery was being tested inside a containment system when it got overheated and caught fire at about 9 a.m. local time, ABC quoted the Houston Fire Department (HFD) sources as reporting.A shelter-in-place was issued for a few buildings because it's believed that one of the bi-products of the combustion could be dangerous, HFD said.The fire was put out before 11:30 a.m.A firefighter was injured when a hydrant cap blew off and struck him, according to ABC.

CANBERRA, June 10 (Xinhua) -- Going to work when you are feeling sick can make you sicker in the long run, an expert told Australia's media on Friday.New Zealand sociologist Professor Kevin Dew from the Victoria University in Wellington, has assessed more than 40 papers about " presenteeism".He defined presenteeism as: "People that are turning up at work when they feel that they should be at home sick.""People feel compelled to go to work because someone else would have to take up the workload (and they have a) feeling of responsibility for not being able to care properly for patients (if they don't show up)," he told the Australia Associated Press on Friday.He said that evidence suggested people who go to work when they are sick can have long term negative effects on health and productivity.Evidence shows that presenteeism increases illness, including musculoskeletal pain, fatigue, depression, and serious coronary events. It also leads to exhaustion which, in turn, leads to more presenteeism.Prof. Dew said certain medical conditions like depression and migraine are also linked with presenteeism because they are not seen as legitimate reasons for absence.He has written an editorial in the latest issue of the British Medical Journal about his findings.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.